Bristol-Myers Squibb Company (BMY) stock advanced in its latest intraday trading, after finding support at its previous 50-day SMA, which provided positive momentum helping it achieve those gains. The stock had earlier managed to unwind its clear overbought levels in the Stochastic indicators, while the short-term corrective bullish wave remains in control.

Therefore, we expect the stock to rise in its upcoming trading, as long as the support level of 46.20 holds, to then target the key resistance level of 49.25 in preparation to test it.

Todays price forecast: Bullish.